ImmuCell Corporation
ICCC
$5.07
-$0.0662-1.29%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 173.34% | 54.19% | -249.76% | 61.58% | -21.26% |
| Total Depreciation and Amortization | -0.19% | 0.61% | 0.55% | -1.13% | -3.64% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 5.88% | 0.99% | 16.09% |
| Total Other Non-Cash Items | -19.45% | -46.60% | 71.85% | -56.52% | -38.46% |
| Change in Net Operating Assets | -86.00% | -148.93% | 903.33% | 136.67% | 16.24% |
| Cash from Operations | 99.52% | -209.88% | 39.02% | 157.88% | -42.40% |
| Capital Expenditure | -121.95% | 20.14% | -57.24% | 13.41% | 80.67% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 200.00% |
| Cash from Investing | -121.95% | 16.76% | -50.85% | -308.28% | 106.34% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -1.60% | -1.07% | -0.80% | -1.32% | 84.66% |
| Issuance of Common Stock | -77.24% | 1,316.82% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -130.12% | 116.92% |
| Cash from Financing | -95.36% | 2,978.23% | 69.55% | -14.03% | -120.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.03% | 582.69% | 2,077.72% | 98.18% | -288.85% |